Anthropic, Defense, Tesla's Optimus | March mARKet Update

Video Description

Please enjoy ARK’s March Fund mARKet Update Webinar. In this month’s on-demand webinar, Cathie Wood and the ARK team explore AI's transformative role in software development, investment strategies in emerging technologies like silicon photonics, and the evolving landscape of quantum computing, emphasizing market opportunities and challenges. ARK publishes a brand new webinar every month. Investors are encouraged to submit questions ahead of the recording of each webinar on X by mentioning our Funds account @ARK_Funds. Key Points: 00:00:00 Intro 00:06:35 We ran a poll on X asking what you wanted to hear about in this webinar, and the winner was Space & Defense… Daniel, could you give a quick update on the Space & Defense industry overall, noting that the outlook may evolve quickly given current geopolitical developments and difference between recording and publication of this webinar? 00:09:24 In what year are you expecting Optimus to have an impact on Tesla’s earnings? 00:11:51 What is your stance on the recent competitive landscape and shifts among OpenAI, Anthropic, and Microsoft and how will that impact the three companies? 00:17:06 What do you think will catalyze performance in ARKG? Will the multiomics market catch up to the rest of the innovation platforms? 00:33:40 What is your near-term view on bitcoin? 00:36:40 Do you believe it would have made more sense for xAI to merge with Tesla because then you could combine AI teams? The SpaceX and xAI merger gives an appearance that SpaceX will play favorites in deploying space compute. Is there a monopoly risk to merging these companies? 00:41:00 Recursion (RXRX) has been an underperformer recently. What do you think will turn the stock around? For a full list of holdings and fund details, click here: https://ark-funds.com/our-etfs/ Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal will fluctuate so that an investor’s shares when redeemed may be worth more or less than the original cost. For the Fund’s most recent month end performance, please visit www.ark-funds.com or call1-800-679-7759.